Daewon Pharmaceutical Co Ltd
KRX:003220
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Daewon Pharmaceutical Co Ltd
Cash from Operating Activities
Daewon Pharmaceutical Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Daewon Pharmaceutical Co Ltd
KRX:003220
|
Cash from Operating Activities
₩42.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
|
Yuhan Corp
KRX:000100
|
Cash from Operating Activities
₩106.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
30%
|
CAGR 10-Years
-2%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Cash from Operating Activities
₩176.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Cash from Operating Activities
₩173.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Cash from Operating Activities
₩9.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
25%
|
CAGR 10-Years
-6%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Cash from Operating Activities
₩18.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Daewon Pharmaceutical Co Ltd
Glance View
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products include antipyretics, analgesics, anti-inflammatory drugs, respiratory drugs, gastrointestinal drugs, antimicrobial drugs, cardiovascular drugs, metabolic drugs, psychoneurotic drugs, neuromuscular drugs, endocrine drugs and others. The firm also produces multivitamins and health foods. The firm distributes its products within domestic market and overseas markets, including Vietnam, Myanmar, Southeast Asia, the Middle East and others.
See Also
What is Daewon Pharmaceutical Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
42.3B
KRW
Based on the financial report for Dec 31, 2025, Daewon Pharmaceutical Co Ltd's Cash from Operating Activities amounts to 42.3B KRW.
What is Daewon Pharmaceutical Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
5%
Over the last year, the Cash from Operating Activities growth was 41%. The average annual Cash from Operating Activities growth rates for Daewon Pharmaceutical Co Ltd have been 17% over the past three years , 11% over the past five years , and 5% over the past ten years .
